References
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
Spaulding CM, Joly L, Rosenberg A, Monchi M, Weber SN, Dhainaut JA, Carli P. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629-1633.
Garan H. Ruskin Jn, DiMarco JP, Derkac WM, Akins CW, Daggett WM, Austen WG, Buckley MJ. Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias. Am J Cardiol 1983;51:519-524.
Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-1575.
Grossman E, Messerli FH, Grodzicki T, Kowey PR. Should a moratorium be place on sublingual nifedipine? JAMA 1996;276:1328-1332.
Norweigan Multicenter Study Group. Timolol-induced reductionin mortality and reinfarction with long-term beta-adrenoreceptor blockade. Br Med J 1977;2:419-421.
Julian DG, Camm AJ, Franagin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on normality in patients with left ventricular dysfunction of the recent myocardial infarction: EMIAT. Lancet 1997;349:667-674.
Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study, Hamburg). Am Heart J 1994;127:1139-1144.
The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-533.
Kober L, Torp-Pederson C, Carlsen JE, et al. A clinical trail of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670-1676.
Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
Zehender M, Faber T, Koscheck U, Meinertz T, Just H. Ventricular tachyarrhythmias, myocardial ischemia, and sudden cardiac death in patients with hypertensive heart disease. Clin Cardiol 1995;18:377-383.
Rials SJ, Wu Ying, Xu X, Filart RA, Marinchak RA, Kowey PR. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 1997;96:1330-1336.
Rights and permissions
About this article
Cite this article
Kowey, P., Marinchak, R.A., Rials, S.J. et al. Antiarrhythmic Impact of Non-antiarrhythmic Cardiovascular Therapies. Card Electrophysiol Rev 2, 123–126 (1998). https://doi.org/10.1023/A:1009959128056
Issue Date:
DOI: https://doi.org/10.1023/A:1009959128056